Tower Research Capital (TRC)’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
9,148
+1,188
| +15% | +$15.6K | ﹤0.01% | 2232 |
|
|
2025
Q1 | $175K | Buy |
7,960
+4,284
| +117% | +$94.2K | 0.01% | 1441 |
|
|
2024
Q4 | $98.1K | Buy |
3,676
+3,369
| +1,097% | +$90K | ﹤0.01% | 2149 |
|
|
2024
Q3 | $8.19K | Sell |
307
-5,283
| -95% | -$141K | ﹤0.01% | 3977 |
|
|
2024
Q2 | $101K | Buy |
5,590
+5,120
| +1,089% | +$92.2K | ﹤0.01% | 2577 |
|
|
2024
Q1 | $8.57K | Sell |
470
-17,767
| -97% | -$324K | ﹤0.01% | 3997 |
|
|
2023
Q4 | $200K | Buy |
18,237
+12,181
| +201% | +$133K | ﹤0.01% | 2101 |
|
|
2023
Q3 | $34.7K | Buy |
6,056
+4,833
| +395% | +$27.7K | ﹤0.01% | 2893 |
|
|
2023
Q2 | $9.48K | Sell |
1,223
-15,177
| -93% | -$118K | ﹤0.01% | 4251 |
|
|
2023
Q1 | $109K | Buy |
16,400
+9,796
| +148% | +$65.1K | ﹤0.01% | 1792 |
|
|
2022
Q4 | $59K | Buy |
6,604
+2,829
| +75% | +$25.3K | ﹤0.01% | 2222 |
|
|
2022
Q3 | $37K | Buy |
3,775
+2,555
| +209% | +$25K | ﹤0.01% | 3423 |
|
|
2022
Q2 | $10K | Sell |
1,220
-922
| -43% | -$7.56K | ﹤0.01% | 4442 |
|
|
2022
Q1 | $21K | Buy |
2,142
+861
| +67% | +$8.44K | ﹤0.01% | 3481 |
|
|
2021
Q4 | $20K | Buy |
1,281
+810
| +172% | +$12.6K | ﹤0.01% | 3661 |
|
|
2021
Q3 | $8K | Buy |
471
+177
| +60% | +$3.01K | ﹤0.01% | 4533 |
|
|
2021
Q2 | $6K | Buy |
+294
| New | +$6K | ﹤0.01% | 4623 |
|